Ivan Jambor
 
 ivjamb@utu.fi  | 
- Improved diagnostic performance of a phage display antibody-assisted intact free PSA assay as used in the four kallikrein concept applied to the IMPROD/multi-IMPROD study  (2025)  
- Clinica Chimica Acta
 
 - Long‐Term Risk of Clinically Significant Prostate Cancer in Biopsy‐Negative Patients With Baseline Biparametric Prostate MRI  (2025)  
- Journal of Magnetic Resonance Imaging
 
 - Prospective comparison of 18F-PSMA-1007 PET/CT and MRI with histopathology as the reference standard for intraprostatic tumour detection and T-staging of high-risk prostate cancer  (2025)  
- European Journal of Nuclear Medicine and Molecular Imaging
 
 - Differences in Gut Microbiota Profiles and Microbiota Steroid Hormone Biosynthesis in Men with and Without Prostate Cancer  (2024)  
- European Urology Open Science
 
 - Relaxation Along a Fictitious Field, continuous wave T1rho, adiabatic T1rho and adiabatic T2rho imaging of human gliomas at 3T: A feasibility study  (2024)  
- PLoS ONE
 
 - Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors  (2023)  
- World Journal of Urology
 
 - Low-Field Portable Magnetic Resonance Imaging for Post-Thrombectomy Assessment of Ongoing Brain Injury  (2023)  
- Stroke : vascular and interventional neurology
 
 - Prostate cancer detection and segmentation on MRI using non-local mask R-CNN with histopathological ground truth  (2023)  
- Medical Physics
 
 - Reply by Authors  (2023)  
- Journal of Urology
 
 - Unilateral Pelvic Lymph Node Dissection in Prostate Cancer Patients Diagnosed in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Study That Challenges the Dogma  (2023)  
- Journal of Urology
 
 - Value of 68Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [18F]fluoromethylcholine PET-CT and multiparametric MRI—a phase I/II study  (2023)  
- European Radiology
 
 - Association between Incidental Pelvic Inflammation and Aggressive Prostate Cancer  (2022)  
- Cancers
 
 - Comparison of reprojected bone SPECT/CT and planar bone scintigraphy for the detection of bone metastases in breast and prostate cancer  (2022)  
- Nuclear Medicine Communications
 
 - Detection of Prostate Cancer Using Biparametric Prostate MRI, Radiomics, and Kallikreins: A Retrospective Multicenter Study of Men With a Clinical Suspicion of Prostate Cancer  (2022)  
- Journal of Magnetic Resonance Imaging
 
 - Expanding Active Surveillance Inclusion Criteria: A Novel Nomogram Including Preoperative Clinical Parameters and Magnetic Resonance Imaging Findings  (2022)  
- European Urology Oncology
 
 - Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0)  (2022)  
- BMJ Open
 
 - Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a Magnetic Resonance Imaging–detected Prostate Imaging Reporting and Data System/Likert ≥3 Lesion: Development and Multinational External Validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk Score  (2022)  
- European Urology
 
 - Quicksort leave-pair-out cross-validation for ROC curve analysis  (2022)  
- Computational Statistics
 
 - The Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Significant Prostate Cancer: Development of a Risk Predictive Tool and Validation with Advanced Neural Networking, Prostate Magnetic Resonance Imaging Outcome Database, and European Randomized Study of Screening for Prostate Cancer Risk Calculator  (2022)  
- European Urology Open Science
 
 - When to order genomic tests: development and external validation of a model to predict high-risk prostate cancer at the genotypic level  (2022)  
- World Journal of Urology
 
 



